CN105055708A - Medicine for treating nephritis - Google Patents
Medicine for treating nephritis Download PDFInfo
- Publication number
- CN105055708A CN105055708A CN201510450284.9A CN201510450284A CN105055708A CN 105055708 A CN105055708 A CN 105055708A CN 201510450284 A CN201510450284 A CN 201510450284A CN 105055708 A CN105055708 A CN 105055708A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- nephritis
- rhizoma alismatis
- herba pyrolae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a medicine for treating nephritis. The medicine is prepared from the following medicinal raw materials in parts by weight: 40 parts of codonopsis pilosula, 30 parts of astragalus membranaceus, 10 parts of rhizoma alismatis, 6 parts of gynostemma pentaphylla, 6 parts of cassia bark, 5 parts of herba pyrolae, 10 parts of Siwakuai and 8 parts of flos cleistocalycis. According to the medicine disclosed by the invention, the codonopsis pilosula is capable of tonifying middle-Jiao and qi, strengthening spleen and tonifying lung; the astragalus membranaceus is capable of invigorating qi for strengthening superficies, inducing diuresis and expelling toxin; the rhizoma alismatis has functions of inducing urination and clearing damp and hot; the gynostemma pentaphylla is effective in clearing away heat and toxic materials; the cassia bark is capable of tonifying fire and helping yang; the herba pyrolae has functions of clearing dampness, strengthening muscles and bones, and stopping bleeding; the Siwakuai is capable of resolving toxin and dispersing swelling; and the flos cleistocalycis is effective in expelling dampness and relieving stagnation. The medicine, by combining the medicinal raw materials, is capable of regulating triple energizer, and has functions of tonifying the kidney, invigorating spleen and clearing lung so as to effectively treat nephritis. Clinical experiments prove that the medicine disclosed by the invention can be used for safely and effectively treating nephritis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of nephritis.
Background technology
Glomerulonephritis is one group of allergic disease based on glomerular epithelial cell, is called for short nephritis.Clinical main manifestations has the change, edema, hypertension etc. of urine.The cause of disease of this disease and pathogenesis doctor trained in Western medicine do not provide to be explained completely, and a large amount of experiments and clinical research are thought to be caused by immune factor, are mainly allergy.Common with young man.First the patient of 40% finds hematuria and seeks medical advice; There is edema in the case of 90%, sees the puffiness of the eyes after the lighter rises morning, and severe one edema is prolonged and whole body.Even occur hydrothorax, ascites, occur out of breath and abdominal distention, some patients's blood pressure raises and has headache, and urine chemical examination is nearly all containing protein (albuminuria).
Current western medical treatment nephritis mostly is symptomatic treatment, does not have specific drug.With prevention of water, sodium retention, controlled circulation blood volume, thus reach mitigation symptoms, prevention lethal complication, renal function protecting are main.Medication multiselect thiazide diuretic, vasodilator, ganglionic block agents, calcium ion channel blocker etc.Severe patient uses dialysis treatment.But all cure the symptoms, not the disease, a tax on one's mind act of losing money.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of nephritis, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing nephritis.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for nephritis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Codonopsis 40 parts, the Radix Astragali 30 parts, Rhizoma Alismatis 10 parts, Herb Gynostemmae Pentaphylli 6 parts, Cortex Cinnamomi 6 parts, Herba Pyrolae 5 parts, four tile fragment 10 parts, Flos Cleistocalycis Operculati 8 parts.
Inventor thinks: the formation of this disease is relevant with the dirty functional disorder of lung spleen kidney three.It is source on water that lung occupies the part of the body cavity above the diaphragm housing the heart and lungs; The main transmitting and distributing the fluids of the spleen being located in middle-JIAO; Kidney occupies the main water of the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels and takes charge of out entire.Three burnt unfavorable be the first cause of this disease.Only have and this three is dirtyly carried out to conditioning simultaneously and can cure this disease.
The present invention uses: Radix Codonopsis invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Radix Astragali invigorating QI to consolidate the body surface resistance, diuresis poison holding; Rhizoma Alismatis diuresis, clearing away damp-heat; Herb Gynostemmae Pentaphylli heat-clearing and toxic substances removing; It is supporing yang that Cortex Cinnamomi mends fire; The strong muscle hemostasis of Herba Pyrolae damp eliminating; Four tile fragment removing toxic substances and promoting subsidence of swelling; Flos Cleistocalycis Operculati dry disappear stagnant.All medicines share, and play the three burnt people having the same aspiration and interest altogether, effect of Yishen Jianpi lung heat clearing, effectively treats nephritis.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects nephritis patient 80 example for 2012 altogether between year December of December ~ 2014, all from Urology Department outpatient service, and 25 ~ 50 years old age, man 45 example, female 35 example.The course of disease 2 weeks ~ 1 year.
Diagnostic criteria:
The change of urine: have hematuria mostly to be gross hematuria, and occur rapidly oliguria, anuria.
Edema: normal very remarkable.Hypertension: continue raises more.
Other: occurring the interstitial pneumonia symptoms such as cough, hemoptysis, is goodpasture syndrome.
Lab testing: 1. urinating chemical examination has High-grade Proteinuria, Urine sediments analyzer visible red cell, leukocyte and various cast 2. routine blood test chemical examination have anemia 3. plasma protein reduction, and blood urea nitrogen, creatinine raise, CO2 combining power, CO2 CP reduction etc.
Meet the patient of above-mentioned diagnostic criteria.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Hepatic and renal function is abnormal or with serious primary disease etc.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.6 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " nephritis efficacy assessment standard ".
1. complete incidence graph symptom and positive sign disappear completely, and urine protein and erythrocyte continue to turn out cloudy, urine protein quantitation < 0.2/24h, and graft function keeps normal, continues more than 3 months.
2. basic relief of symptoms and positive sign disappear substantially, and urine protein and erythrocyte comparatively treat front minimizing >=50%, graft function or keep normal, or SCr is unchanged or raise < 50% compared with basic value, continues more than 3 months.
3. effectively symptom and positive sign are clearly better, urine protein and (or) erythrocyte comparatively treats front minimizing >=25%, renal function improves and continues more than 3 months, and SCr comparatively basic value raises < 100%.
4. invalid clinical manifestation and lab testing are without improvement.
3.2 therapeutic outcome
80 routine patient's complete incidence graph 60 examples, basic alleviation 14 example, invalid 4 examples.Total effective rate 95%.There is laxativeness in treatments period 2 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of nephritis, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Radix Codonopsis 40 grams, the Radix Astragali 30 grams, Rhizoma Alismatis 10 grams, Herb Gynostemmae Pentaphylli 6 grams, Cortex Cinnamomi 6 grams, Herba Pyrolae 5 grams, four tile fragment 10 grams, Flos Cleistocalycis Operculati 8 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of nephritis.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Radix Codonopsis 40 grams, the Radix Astragali 30 grams, Rhizoma Alismatis 10 grams, Herb Gynostemmae Pentaphylli 6 grams, Cortex Cinnamomi 6 grams, Herba Pyrolae 5 grams, four tile fragment 10 grams, Flos Cleistocalycis Operculati 8 grams; Add 10 times of water gagings, decoct 2 hours, filtration; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of nephritis.Oral, daily once.
Embodiment 3
Take: Radix Codonopsis 40 grams, the Radix Astragali 30 grams, Rhizoma Alismatis 10 grams, Herb Gynostemmae Pentaphylli 6 grams, Cortex Cinnamomi 6 grams, Herba Pyrolae 5 grams, four tile fragment 10 grams, Flos Cleistocalycis Operculati 8 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of nephritis.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. be used for the treatment of a medicine for nephritis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Codonopsis 40 parts, the Radix Astragali 30 parts, Rhizoma Alismatis 10 parts, Herb Gynostemmae Pentaphylli 6 parts, Cortex Cinnamomi 6 parts, Herba Pyrolae 5 parts, four tile fragment 10 parts, Flos Cleistocalycis Operculati 8 parts.
2. be used for the treatment of the medicine of nephritis as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Codonopsis 40 parts, the Radix Astragali 30 parts, Rhizoma Alismatis 10 parts, Herb Gynostemmae Pentaphylli 6 parts, Cortex Cinnamomi 6 parts, Herba Pyrolae 5 parts, four tile fragment 10 parts, Flos Cleistocalycis Operculati 8 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of nephritis as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Codonopsis 40 parts, the Radix Astragali 30 parts, Rhizoma Alismatis 10 parts, Herb Gynostemmae Pentaphylli 6 parts, Cortex Cinnamomi 6 parts, Herba Pyrolae 5 parts, four tile fragment 10 parts, Flos Cleistocalycis Operculati 8 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filtration; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of nephritis as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Codonopsis 40 parts, the Radix Astragali 30 parts, Rhizoma Alismatis 10 parts, Herb Gynostemmae Pentaphylli 6 parts, Cortex Cinnamomi 6 parts, Herba Pyrolae 5 parts, four tile fragment 10 parts, Flos Cleistocalycis Operculati 8 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510450284.9A CN105055708A (en) | 2015-07-28 | 2015-07-28 | Medicine for treating nephritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510450284.9A CN105055708A (en) | 2015-07-28 | 2015-07-28 | Medicine for treating nephritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105055708A true CN105055708A (en) | 2015-11-18 |
Family
ID=54485385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510450284.9A Pending CN105055708A (en) | 2015-07-28 | 2015-07-28 | Medicine for treating nephritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055708A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105616617A (en) * | 2016-02-29 | 2016-06-01 | 张向华 | Medicine for treating acute glomerulonephritis |
| CN109316494A (en) * | 2017-07-31 | 2019-02-12 | 何晓燕 | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623458A (en) * | 2008-07-11 | 2010-01-13 | 北京天科仁祥医药科技有限公司 | Chinese medicament preparation for clearing away heat and promoting diuresis, and removing damp and toxin and preparation method thereof |
| CN102430015A (en) * | 2011-12-13 | 2012-05-02 | 朱友文 | Traditional Chinese medicinal preparation for treating nephritis and uremia as well as preparation method thereof |
| CN103301245A (en) * | 2013-06-03 | 2013-09-18 | 安徽华佗国药股份有限公司 | Medicament for reinforcing qi, nourishing blood and nourishing liver and kidney |
| CN104353047A (en) * | 2014-11-24 | 2015-02-18 | 时成伍 | Traditional Chinese medicine for treating nephritis |
-
2015
- 2015-07-28 CN CN201510450284.9A patent/CN105055708A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623458A (en) * | 2008-07-11 | 2010-01-13 | 北京天科仁祥医药科技有限公司 | Chinese medicament preparation for clearing away heat and promoting diuresis, and removing damp and toxin and preparation method thereof |
| CN102430015A (en) * | 2011-12-13 | 2012-05-02 | 朱友文 | Traditional Chinese medicinal preparation for treating nephritis and uremia as well as preparation method thereof |
| CN103301245A (en) * | 2013-06-03 | 2013-09-18 | 安徽华佗国药股份有限公司 | Medicament for reinforcing qi, nourishing blood and nourishing liver and kidney |
| CN104353047A (en) * | 2014-11-24 | 2015-02-18 | 时成伍 | Traditional Chinese medicine for treating nephritis |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105616617A (en) * | 2016-02-29 | 2016-06-01 | 张向华 | Medicine for treating acute glomerulonephritis |
| CN109316494A (en) * | 2017-07-31 | 2019-02-12 | 何晓燕 | Purposes of the badger seed oil in preparation treatment ephritis medicine or health food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104645132B (en) | A kind of Chinese medicine composition that treating diabetic nephropathy, preparation method, Chinese medicine preparation and application | |
| CN104173950B (en) | A kind of herbal composite for treating prostate cancer | |
| CN105055708A (en) | Medicine for treating nephritis | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN101804126A (en) | Application of traditional Chinese medicine composition in treating qi-blood deficiency and spleen-kidney deficiency and preparation method thereof | |
| CN102028897B (en) | Chinese patent drug for treating glomerular hematuria and preparation method thereof | |
| CN101040923B (en) | Chinese traditional medicine for treating pelvic inflammation | |
| CN102813757B (en) | Preparation method of traditional Chinese medicine for treating lumbago type acute glomerulonephritis | |
| CN106620435B (en) | Traditional Chinese medicine composition for treating gouty arthritis and application thereof | |
| CN106236857B (en) | Traditional Chinese medicine composition for treating chronic renal failure and preparation method, preparation and application thereof | |
| CN116585432B (en) | Pharmaceutical composition, preparation method thereof and application thereof in preparing detoxication and kidney tonifying medicines | |
| CN104491102B (en) | Colon positioning traditional Chinese medicine preparation for treating chronic kidney failure | |
| CN103520538B (en) | A kind ofly treat the pharmaceutical composition that diabetes cause kidney damage | |
| CN102793903B (en) | Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis | |
| CN102861192A (en) | Medicine composition for chronic renal failure and peritoneal fibrosis | |
| CN109223951B (en) | Traditional Chinese medicine for treating yin deficiency and fire excess syndrome of purpuric nephritis in children | |
| CN104840769B (en) | A kind of Chinese medicine for treating Sjogren syndrome | |
| CN105288410A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and application of traditional Chinese medicine composition | |
| CN105343535A (en) | Enema preparation for treatment of diabetic nephropathy | |
| CN116474036A (en) | Traditional Chinese medicine composition and application thereof | |
| CN102973918B (en) | Traditional Chinese medicine for treating nephritis | |
| CN102772630B (en) | Medicine for treating type-II diabetes mellitus | |
| CN103989841A (en) | Pharmaceutical composition for treatment of epidemic hemorrhagic fever | |
| CN104606596A (en) | Chinese patent medicine for treating behcet disease and preparation method of Chinese patent medicine | |
| CN115607644A (en) | Traditional Chinese medicine composition for treating IgA nephropathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151118 |
|
| WD01 | Invention patent application deemed withdrawn after publication |